logo
Plus   Neg
Share
Email
Comment

Corcept Therapeutics Inc. (CORT) Pulled Back On News Of Generic Competition

Corcept Therapeutics Inc. (CORT) gapped open sharply lower Monday and dropped further in early trade, before settling into a range. Shares finished with a loss of 6.20 at $17.26 on strong volume. The stock dropped to over a 1-month low.

Corcept Therapeutics was under pressure after Teva Pharmaceutical Industries (TEVA) submitted a new drug application for a generic version of the company's Korlym drug.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

comments powered by Disqus
Follow RTT